Overview

STAT-STatin and Aspirin in Trauma

Status:
Active, not recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

This is a phase II, pragmatic, prospective, randomized, double-blind, adaptive clinical trial examining the efficacy of statins and aspirin in the reduction of acute lung injury and venous thromboembolism in patients with fibrinolysis shutdown.

Phase:

Phase 2

Details

Lead Sponsor:

Denver Health and Hospital Authority

Treatments:

Aspirin
Rosuvastatin Calcium